Leiner recapitalization complete
This article was originally published in The Tan Sheet
Executive Summary
Sale of North Castle Partners' majority stake in private labeler Leiner Health Products is finalized, the private equity firm announces May 27. A $265 mil. investment in Leiner by private equity firm Golden Gate and North Castle makes the two firms co-sponsors of Leiner and is part of the $650 mil. recapitalization. North Castle talked with several equity firms prior to announcing the deal (1"The Tan Sheet" Feb. 23, 2004, p. 3)...
You may also be interested in...
Leiner Ownership Expected To Change Hands In Recapitalization Deal
North Castle Partners is reportedly in the second round of talks to sell its stake in Leiner Health Products to another private equity firm
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.